264 related articles for article (PubMed ID: 24059399)
1. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation.
Jeong HT; Kim MJ; Chung YE; Choi JY; Park YN; Kim KW
AJR Am J Roentgenol; 2013 Oct; 201(4):W603-11. PubMed ID: 24059399
[TBL] [Abstract][Full Text] [Related]
2. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
[TBL] [Abstract][Full Text] [Related]
3. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
Kang Y; Lee JM; Kim SH; Han JK; Choi BI
Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
[TBL] [Abstract][Full Text] [Related]
6. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
[TBL] [Abstract][Full Text] [Related]
7. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.
Mamone G; Marrone G; Caruso S; Carollo V; Gentile G; Crino' F; Milazzo M; Luca A
Abdom Imaging; 2015 Oct; 40(7):2313-22. PubMed ID: 25962708
[TBL] [Abstract][Full Text] [Related]
9. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
10. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.
Watanabe H; Kanematsu M; Goshima S; Kondo H; Onozuka M; Moriyama N; Bae KT
Radiology; 2011 Apr; 259(1):142-50. PubMed ID: 21248234
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography.
Kim JE; Lee JM; Kim SH; Baek JH; Moon SK; Yu IS; Kim SH; Lee JY; Han JK; Choi BI
Radiology; 2010 Nov; 257(2):364-72. PubMed ID: 20829532
[TBL] [Abstract][Full Text] [Related]
12. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.
Goshima S; Kanematsu M; Watanabe H; Kondo H; Shiratori Y; Onozuka M; Moriyama N
AJR Am J Roentgenol; 2010 Oct; 195(4):941-6. PubMed ID: 20858822
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics.
Choi JY; Kim MJ; Park YN; Lee JM; Yoo SK; Rha SY; Seok JY
AJR Am J Roentgenol; 2011 Aug; 197(2):399-405. PubMed ID: 21785086
[TBL] [Abstract][Full Text] [Related]
16. Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.
Tamada T; Ito K; Yamamoto A; Sone T; Kanki A; Tanaka F; Higashi H
AJR Am J Roentgenol; 2011 Apr; 196(4):824-30. PubMed ID: 21427331
[TBL] [Abstract][Full Text] [Related]
17. Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.
Kim SH; Lee CH; Kim BH; Kim WB; Yeom SK; Kim KA; Park CM
J Comput Assist Tomogr; 2012; 36(6):704-9. PubMed ID: 23192208
[TBL] [Abstract][Full Text] [Related]
18. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.
Onishi H; Theisen D; Dietrich O; Reiser MF; Zech CJ
J Magn Reson Imaging; 2014 Jan; 39(1):42-50. PubMed ID: 24339365
[TBL] [Abstract][Full Text] [Related]
19. MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography?
Reiner CS; Merkle EM; Bashir MR; Walle NL; Nazeer HK; Gupta RT
AJR Am J Roentgenol; 2013 Jul; 201(1):W49-56. PubMed ID: 23789696
[TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.
Yamada A; Hara T; Li F; Fujinaga Y; Ueda K; Kadoya M; Doi K
Radiology; 2011 Sep; 260(3):727-33. PubMed ID: 21712472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]